Literature DB >> 4172471

Antifungal agents in bronchopulmonary aspergillosis.

D S McCarthy, D G Robertson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4172471     DOI： 10.1016/s0140-6736(68)91439-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  1 in total

1.  Controlled trial of natamycin in the treatment of allergic bronchopulmonary aspergillosis.

Authors:  D C Currie; C Lueck; H J Milburn; C Harvey; J L Longbottom; J H Darbyshire; A J Nunn; P J Cole
Journal:  Thorax       Date:  1990-06       Impact factor: 9.139
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.